Published 28 November 2008, doi:10.1136/bmj.a531
Cite this as: BMJ 2008;337:a531

Practice

Lesson of the Week

Fatal thyrotoxic cardiomyopathy in a young man

May Ching Soh, rheumatology research registrar1, Michael Croxson, endocrinologist2

1 Department of Medicine, North Shore Hospital, Auckland, New Zealand, 2 Department of Endocrinology, Greenlane Clinical Centre, Auckland

Correspondence to: M Croxson, Thyroid Clinic, Greenlane Clinical Centre, PO Box 92-189, Auckland, New Zealand MichaelC@adhb.govt.nz

β blockers may precipitate circulatory collapse in thyrotoxic patients with low output heart failure

The first 150 words of the full text of this article appear below.

Epidemiological studies show an excess vascular mortality associated with hyperthyroidism, even after radioiodine treatment, and in people aged under 50.1 2 Thyrotoxic cardiomyopathy is a distinct clinical entity with devastating clinical consequences. It can affect young people even in the absence of underlying cardiac disease.3 4 It often presents as heart failure. Most cases are reversible, with cardiac function improving after thyroid function returns to normal.4 5 6 7 However, in the acute setting, the severity of the illness may result in fatalities despite treatment.8 9 10 This represents an important exception to the general principle that β blockers should be used in most hyperthyroid patients with tachyarrhythmias.

We present the case of a young man with chronic hyperthyroid Graves’ disease, who was admitted to hospital with severe heart failure, rapid atrial fibrillation, and pneumonia and died despite resuscitation.

A man in his 20s with known hyperthyroid Graves’ disease was admitted to hospital critically ill after five . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

β blockers and decompensated heart failure
Jonathan R Dalzell
BMJ 2009 338: b955. [Extract] [Full Text]

This article has been cited by other articles:

  • Dalzell, J. R (2009). {beta} blockers and decompensated heart failure. BMJ 338: b955-b955 [Full text]  

Rapid Responses:

Read all Rapid Responses

re. Fatal thyrotoxic cardiomyopathy in a young man
Adam P Morton
bmj.com, 20 Feb 2009 [Full text]
This death might have been avoided had metabolic meme complexes guided management.
Richard G Fiddian-Green
bmj.com, 21 Feb 2009 [Full text]
Beta-blockers and decompensated heart failure: never the twain shall meet.
Jonathan R Dalzell
bmj.com, 21 Feb 2009 [Full text]
Fatal thyrotoxic cardiomyopathy in a young man - the authors' response
Michael Croxson, et al.
bmj.com, 23 Mar 2009 [Full text]
Intravenous beta-blockade in the pulmonary oedema of thyroid storm
Michael J Daly, et al.
bmj.com, 7 May 2009 [Full text]
Re: Intravenous beta-blockade in the pulmonary oedema of thyroid storm
Michael S Croxson, et al.
bmj.com, 26 May 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ